Macular degeneration trials in Lithuania

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  Where

  Kaunas, Vilnius

  Age

  50 years and over

  People

  304 worldwide

  Run by

  Amgen

  See details and how to joinNCT07614776 · EU 2025-523500-72-00
• Phase 3Active, not recruiting
  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  Where

  Kaunas, Vilnius

  Age

  50 years and over

  People

  480 worldwide

  Run by

  4D Molecular Therapeutics

  See details and how to joinNCT07064759